AI can't borrow anymore so it's selling stock instead — Anthropic's record IPO makes JPMorgan the fee machine
Wall Street is hitting the limits of how much AI-related debt it can absorb, which pushes AI companies toward raising money by selling shares rather than borrowing — that means a wave of large IPOs. Anthropic choosing JPMorgan to lead its potentially record-setting US retail offering puts one of the biggest franchise banks first in line for underwriting fees. As the AI funding mix shifts from loans to share sales, the banks that run those deals capture fee income regardless of whether AI stocks themselves go up or down.
Idea
Wall Street is hitting the limits of how much AI-related debt it can absorb, which pushes AI companies toward raising money by selling shares rather than borrowing — that means a wave of large IPOs. Anthropic choosing JPMorgan to lead its potentially record-setting US retail offering puts one of the biggest franchise banks first in line for underwriting fees. As the AI funding mix shifts from loans to share sales, the banks that run those deals capture fee income regardless of whether AI stocks themselves go up or down.
Advanced Analysis — institutional-depth research report
Verdict: a real fee story on JPMorgan, but the rules say wait — not one condition is live today
Our stance over the next three months is to wait: the Anthropic-led AI-IPO fee thesis is credible but unconfirmed, and the strategy's entry conditions produced zero triggers across the 22 daily bars evaluated in the last month. The strongest point for the idea is that JPMorgan's franchise is already compounding — Q2 2026 net income of $21.2B, up 28.3% from the prior quarter, with the dividend raised to $6.15 per share for 2026 — so any IPO fee stream would be incremental rather than a rescue. The strongest point against is that the entire catalyst rests on two same-day Bloomberg reports from October 28, 2026 using "said to" language, while provisional ownership filings for the period ending September 30, 2026 show about $6.6M of net open-market insider selling. Mechanically, the entry requires a close above the 50-day average ($339.78) and below the Bollinger midline ($333.57) at the same time with RSI between 42 and 58 — conditions that currently point in opposite directions, with the last close at $335.79. Historical performance was never measured because JPM's raw and adjusted price series use different bases, so this is a watch-list setup on live levels, not a proven trade. A confirmed, dated Anthropic filing — or a quarter where net income falls back toward the $13–15B run rate of late 2025 — would be the fact that changes this verdict.
Trade now
**Wait for the entry conditions — do not act today.** The idea argues a bullish case for JPMorgan as a fee beneficiary if AI fundraising shifts from loans to share sales (with Anthropic reportedly picking JPM to lead a potentially record-setting retail offering). That business thesis can be attractive on its own terms, but today's entry conditions are not met: over the last month the strategy's compiled rules evaluated 22 daily bars and opened zero entries. This is a watch-list setup, not a defective trade. One factual scope note: historical performance for this strategy was never measured because JPM's raw and adjusted price series use different bases, so nothing supports or undermines the rules from history — the decision rests on the live levels below. The horizon is unspecified by the idea; the strategy itself runs on daily bars with exits set at a 90-bar time limit, a fixed 2% stop, and a fixed 4% take-profit — a roughly 2:1 reward-to-risk shape per trade. The pivotal condition is a specific pullback-and-reclaim state: the daily close back above the 50-day average (currently $339.78) while still below the 20-day Bollinger midline (currently $333.57), with RSI between 42 and 58. The downside that matters is a clean break below the second support level near $330 or the 2% stop, whichever binds first. "Waiting" means concretely: JPM last closed at $335.79 as of the October 28, 2026 market-state computation — $3.99 below the 50-day average and $2.22 above the band midline. The entry requires both at once, so either JPM must dip below roughly $333.57 while the 50-day average holds above it and momentum stays mid-range, or the averages must converge. Note the structural tension: with the midline sitting below the average, the two price conditions currently point in opposite directions, which is why nothing has triggered. Do not pre-position on the thesis alone. ### Technical details - **Entry rule (long, JPM daily):** close above the 50-day EMA — currently $339.78 vs. last close $335.79, needs a rise of about $3.99 (status: near). Close below the Bollinger (20) midline — currently $333.57, price is $2.22 above it (status: near). RSI (14) above 42 and below 58 — currently 52.5, both met. All four must hold on the same bar. - **Take-profit rules:** close at or above the first resistance level ($340, only ~$4.21 above the last close), or a fixed +4% on the position. - **Stop rules:** a close crossing the second support level ($330), or a fixed -2% loss on the position. - **Time exit:** any position is closed after 90 daily bars regardless of profit. - **Sizing:** fixed-risk method risking 2% per position, capped at 25% of the portfolio. - **Context:** JPM trades 7.7% below its 250-day range high and 18.7% above its range low; the 50-day SMA sits at $344.49 and the 200-day SMA at $322.44. The UNDER symbol had no usable price data (zero candles), so no second-leg watch is possible. Company fundamentals are supportive of the franchise thesis — Q2 2026 net income of $21.2B, up 28.3% from the prior quarter — but that is background, not an entry signal.
Bull case: a fee windfall lands on the strongest balance sheet in the group
The bull case has real support in JPMorgan's reported numbers, though the entry signal has not yet fired, so this is a watch-list idea rather than an active trade. ### Record earnings momentum is already in the books JPMorgan reported net income of $21.2B for the quarter ended June 30, 2026, up 28.3% from $16.5B the prior quarter, with quarterly return on equity (profit as a share of shareholder capital) rising from 4.5% to 5.6%. The idea's thesis — that underwriting fees from a wave of AI-related share sales flow to lead banks — arrives on top of a franchise that is already compounding: full-year 2025 net income was $57.0B on $182.4B of revenue, versus $24.4B on $100.7B in 2017. Strong current earnings mean the IPO fee stream is incremental, not a rescue. ### The Bloomberg reporting directly supports the thesis mechanism Per the Bloomberg report dated October 28, 2026, Anthropic picked JPMorgan to lead the US retail portion of what could be a record-setting IPO, and a second Bloomberg piece the same day argues Wall Street's AI debt machine is "starting to choke on supply" — the exact funding-mix shift from loans to share sales the idea is built on. The causal chain is concrete: capped debt capacity forces equity issuance, issuers choose lead banks with distribution scale, and JPMorgan collects advisory and underwriting fees that land in reported revenue regardless of where AI stock prices go afterward. ### Cash returns keep compounding while the share count shrinks The dividend has grown every year since 2021, from $4.00 per share to $6.15 in 2026 (a 10.8% annual growth rate), and the latest quarterly payment stepped up to $1.65 per share with an ex-date of…
Scores
- Conviction score breakdown: 51
- Thesis support: 55
- Trade readiness: 30
- Risk quality: 45
- Trigger proximity: 50
- Fundamentals trend: 75
Watch items
- JPM — Daily close vs 50-day EMA
- JPM — Daily close vs Bollinger (20) midline
- JPM — RSI (14)
- JPM — Close vs second support level
- JPM — First resistance level (take-profit)